Effects of fecal microbiota transplantation on liver function and blood ammonia in hepatic encephalopathy rats

Weiwei WANG; Yu ZHANG; Nan YOU; Lu ZHENG; Jing LI

doi:10.16016/j.1000-5404.201610152

您当前的位置：

首页 >

文章列表页 >

Effects of fecal microbiota transplantation on liver function and blood ammonia in hepatic encephalopathy rats

Basic Medicine | 更新时间：2026-01-09

- Effects of fecal microbiota transplantation on liver function and blood ammonia in hepatic encephalopathy rats
- Journal of Third Military Medical University Vol. 39, Issue 13, Pages: 1321-1326(2017)
- 作者机构：
  
  400037 重庆，第三军医大学新桥医院肝胆外科
- 作者简介：
- 基金信息：
- DOI：10.16016/j.1000-5404.201610152
  CLC： R333.4;R378.2;R575.3
- Received：24 October 2016，
  
  Revised：2017-01-04，
  
  Published：15 July 2017
- 稿件说明：
移动端阅览
Weiwei WANG, Yu ZHANG, Nan YOU, et al. Effects of fecal microbiota transplantation on liver function and blood ammonia in hepatic encephalopathy rats[J]. Journal of Third Military Medical University, 2017, 39(13): 1321-1326.
DOI：

Weiwei WANG, Yu ZHANG, Nan YOU, et al. Effects of fecal microbiota transplantation on liver function and blood ammonia in hepatic encephalopathy rats[J]. Journal of Third Military Medical University, 2017, 39(13): 1321-1326. DOI： 10.16016/j.1000-5404.201610152.

摘要

目的

建立大鼠肝性脑病及FMT细菌模型，确定粪便细菌移植对肝性脑病大鼠肝功能及血氨的影响

初步了解粪便细菌移植(fecal microbiota transplantation

FMT)的临床意义。

方法

选择32只SD大鼠，采用CCL

+酒精的方法建立大鼠肝性脑病模型及肠道埋管，分为4组(A组：正常对照组；B组：肝性脑病模型组；C组：益生菌组；D组：FMT组)，对C组进行益生菌移植，200 μL/d (200 μL益生菌溶液中含益生菌2.7×10

)

持续2周；对D组进行FMT移植，200 μL/d (200 μL粪便细菌溶液中含粪便细菌2.7×10

)，持续2周。记录大鼠一般生存情况及大便情况，对移植前后体重进行比较，测定移植前、后肝功能(ALT、AST、ALB、TB及DB)和门静脉及尾静脉血氨。

结果

所有实验大鼠均未出现死亡；粪便细菌移植后肝性脑病大鼠体重移植前明显增加[D组移植前(225.18±14.81) g，移植后2周(266.83±33.40) g，

0.05

]

；移植后大鼠肝功能较前明显好转[移植后2周ALT：D组与B组分别为(610.49±4.98) U/L和(990.07±4.80) U/L，

0.05；AST：D组与B组分别为(72.46±4.42) U/L和(101.58±2.19) U/L，

0.05；ALB：D组与B组比较ALB明显上升，分别为(24.48±0.12) g/L和(17.53±0.53) g/L，

0.05；TB：D组为(13.45±0.77)μmol/L，B组为(27.20±0.77)μmol/L，

0.05；DB：D组为(10.04±0.09)μmol/L，B组为(16.04±0.51)μmol/L，

0.05

]

；门静脉及尾静脉血氨较移植前明显降低[D组门静脉及尾静脉血氨分别为(26.26±0.30)μmol/L和(23.10±0.35)μmol/L，B组分别为(36.28±1.32)μmol/L和(32.90±0.35)μmol/L，

0.05

]

。

结论

对大鼠进行人体粪便细菌移植是可行的；粪便细菌移植可改善肝性脑病大鼠的肝功能，降低血氨。

Abstract

Objective

To establish a rat model of hepatic encephalopathy (HE) and fecal microbiota transplantation (FMT)

investigate the effects of FMT on liver function and blood ammonia in order to explore the clinical significance of FMT.

Methods

Totally 32 rats were divided into 4 groups with 8 animals in each group

that is

normal control group

HE group

probiotics group

and FMT group. The SD rats model of HE was established through CCL

+ alcohol injection

and the intestinal pipe was buried. The rats of the probiotics group were given probiotics transplantation (200 μL/d

containing probiotics of 2.7×10

)

and those of the FMT group were given FMT (200 μL/d

containing fecal microbiota of 2.7×10

). After 2 weeks' treatment

the survival

defecation

and body weight

liver function (ALT

AST

ALB

TB and DB) and blood ammonia of portal vein and caudal vein before and after transplantation were recorded and compared.

Results

No death was observed in all experimental rats. When compared with the indexes before transplantation

FMT resulted in obvious increase in the body weight (266.83±33.40

225.18±14.81 g

0.05)

significantly improved liver function (FMT group

HE group

ALT: 610.49±4.98

990.07±4.80 U/L

0.05; AST: 72.46±4.42

101.58±2.19 U/L

0.05; ALB: 24.48±0.12

17.53± 0.53 g/L

0.05; TB: 13.45±0.77

27.20±0.77 μmol/L

0.05; DB: 10.04±0.09

16.04±0.51 μmol/L

0.05). The ammonia contents in the portal and tail venous blood were significantly decreased in the rats after than b

efore FMT treatment (26.26±0.30 and 23.10±0.35 μmol/L respectively in the portal and tail venous blood in the FMT group

and 36.28±1.32 and 32.90±0.35 μmol/L in the HE group

0.05).

Conclusion

Human fecal bacteria transplantation is feasible in rats. FMT treatment can improve liver function and reduce the blood ammonia in HE rats.

关键词

Keywords

references

American Association for the Study of Liver Diseases, Euro-pean Association for the Study of the Liver. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases[J]. J Hepatol, 2014, 61(3):642-659. DOI:10.1016/j.jhep.2014.05.042.

PATIDAR K R, BAJAJ J S. Antibiotics for the treatment of hepatic encephalopathy[J]. Metab Brain Dis, 2013, 28(2): 307-312. DOI:10.1007/s11011-013-9383-5.

HUANG E, ESRAILIAN E, SPIEGEL B M R. The cost-effectiveness and budget impact of competing therapies in hepatic encephalopathy-a decision analysis[J]. Alimentary Pharmacology&Therapeutics, 2007, 26(8): 1147-1161. DOI:10.1111/j.1365-2036.2007.03464.x.

BERG A M, FARRAYE F A. Duodenal infusion of stool is more effective than vancomycin in patients with recurrent Clostridium difficile[J]. Evid Based Med, 2013, 18(6): 220-221. DOI:10.1136/eb-2013-101308.

SATOKARI R, MATTILA E, KAINULAINEN V, et al. Simple faecal preparation and efficacy of frozen inoculum in faecal microbiota transplantation for recurrent Clostridium difficile infection—an observational cohort study[J]. Aliment Pharmacol Ther, 2015, 41(1): 46-53. DOI:10.1111/apt.13009.

HAMILTON M J, WEINGARDEN A R, SADOWSKY M J, et al. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection[J]. Am J Gastroenterol, 2012, 107(5): 761-767. DOI:10.1038/ajg.2011.482.

DAI C, GUANDALINI S, ZHAO D H, et al. Antinociceptive effect of VSL#3 on visceral hypersensitivity in a rat model of irritable bowel syndrome: a possible action through nitric oxide pathway and enhance barrier function[J]. Mol Cell Biochem, 2012, 362(1-2): 43-53. DOI:10.1007/s11010-011-1126-5.

中华医学会消化病学分会, 中华医学会肝病学分会.中国肝性脑病诊治共识意见(2013)[J].中国医学前沿杂志(电子版), 2014, 6(2):81-93. DOI:10.3760/cma.j.issn.0254-1432.2013.09.002.

Digestive Disease Association of Chinese Medical Association, Liver Disease Association of Chinese Medical Association. Chinese consensus on the medical diagnosis and treatment of hepatic encephalopathy(2013)[J]. Chin J Front Med Sci(Elect Ver), 2014, 6(2):81-93. DOI:10.3760/cma.j.issn.0254-1432.2013.09.002.

PETROF E O, KHORUTS A. From stool transplants to next-generation microbiota therapeutics[J]. Gastroenterology, 2014, 146(6): 1573-1582. DOI:10.1053/j.gastro.2014.01.004.

VRIEZE A, VAN NOOD E, HOLLEMAN F, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome[J]. Gastroenterology, 2012, 143(4): 913-916. DOI:10.1053/j.gastro.2012.06.031.

KAO D, ROACH B, PARK H, et al. Fecal microbiota transplantation in the management of hepatic encephalopathy[J]. Hepatology, 2016, 63(1): 339-340. DOI:10.1002/hep.28121.

FARJAM M, DEHDAB P, ABBASSNIA F, et al. Thioacetamide-induced acute hepatic encephalopathy in rat: behavioral, biochemical and histological changes.[J]. Iranian Red Crescent medical journal, 2012(3): 164-170.

PLANER J D, PENG Y, KAU A L, et al. Development of the gut microbiota and mucosal IgA responses in twins and gnotobiotic mice[J]. Nature, 2016, 534(7606): 263-266. DOI:10.1038/nature17940.

RIDAURA V K, FAITH J J, REY F E, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice[J]. Science, 2013, 341(6150): 1241214. DOI:10.1126/science.1241214.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effects of fecal microbiota transplantation on liver function and lipid metabolism disorder in rats with nonalcoholic fatty liver disease

Value of cardiac magnetic resonance tissue tracking imaging for assessment of early cardiac function in rats with left ventricular remodeling

Effect of dexmedetomidine on sevoflurane-induced endoplasmic reticulum stress in hippocampus of neonatal rats

Comparison of rat itch model induced by different pruritogens

Levels of alanine aminotransferase and aspartate aminotransferase in coronavirus disease 2019 patients: a meta-analysis

Related Author

张宇

王威巍

左国华

黄小兵

李靖

李亥辰

黎梅

黄睿珏

Related Institution

Department of Otolaryngology, Head and Neck Surgery, First Affiliated Hospital, Army Medical University (Third Military Medical University)

College of Medical Technology, Chongqing Medical and Pharmaceutical College

Experimental Teaching Center, Chongqing Medical University

State Key Laboratory of Trauma, Burns and Combined Injury, Department 2, Institute of Surgery Research, Third Affiliated Hospital, Army Medical University (Third Military Medical University)

Institute of Gastroenterology, First Affiliated Hospital, Army Medical University (Third Military Medical University)

⁰